文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Latest Advanced Techniques for Improving Intestinal Organoids Limitations.

作者信息

Tonini Lisa, Ahn Changhwan

机构信息

Laboratory of Veterinary Physiology, College of Veterinary Medicine, Jeju National University, Jeju, 63243, Republic of Korea.

Veterinary Medical Research Institute, Jeju National University, Jeju, 63243, Republic of Korea.

出版信息

Stem Cell Rev Rep. 2025 May 19. doi: 10.1007/s12015-025-10894-9.


DOI:10.1007/s12015-025-10894-9
PMID:40388043
Abstract

Intestinal organoids are valuable tools across different disciplines, from a clinical aspect to the biomedical research, providing a unique perspective on the complexity of the gastrointestinal system. They are alternatives to common cell lines as they can offer insights into architectural functionality and reduce the use of animal models. A deeper understanding of their organoid characteristics is required to harness their full potential. Despite their beneficial uses and multiple advantages, organoids have limitations that remain unaddressed. This review aims to elucidate the principal limitations of intestinal organoids, investigate structural defects such as the deficiency in a vascularized and lymphatic system, and absence of the microbiome, restrictions in mimicking the physiological gut model, including the lack of an acid-neutralizing system or a shortage of digestive enzymes, and the difficulties in their long-term maintenance and polarity accessibility. Development of innovative techniques to address these limitations will lead to improve in vivo recapitulation and pioneering further advancements in this field.

摘要

相似文献

[1]
Latest Advanced Techniques for Improving Intestinal Organoids Limitations.

Stem Cell Rev Rep. 2025-5-19

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.

APMIS. 2025-9

[4]
Engineering the Future of Regenerative Medicines in Gut Health with Stem Cell-Derived Intestinal Organoids.

Stem Cell Rev Rep. 2025-5-17

[5]
Short-Term Memory Impairment

2025-1

[6]
Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis.

Cochrane Database Syst Rev. 2024-8-27

[7]
Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling.

SLAS Discov. 2025-3

[8]
Vascularised organoids: Recent advances and applications in cancer research.

Clin Transl Med. 2025-3

[9]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[10]
Patient Restraint and Seclusion

2025-1

引用本文的文献

[1]
A human intestinal organoid derived from fetal human colon cells model for studying enteroviral pathogenesis.

Virulence. 2025-12

本文引用的文献

[1]
Human organoids with an autologous tissue-resident immune compartment.

Nature. 2024-9

[2]
Vascular reconstruction of the decellularized biomatrix for whole-organ engineering-a critical perspective and future strategies.

Front Bioeng Biotechnol. 2023-11-13

[3]
Organization of the human intestine at single-cell resolution.

Nature. 2023-7

[4]
Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasis.

Intern Emerg Med. 2023-9

[5]
Hydrogel-in-hydrogel live bioprinting for guidance and control of organoids and organotypic cultures.

Nat Commun. 2023-5-30

[6]
Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies.

Sci Rep. 2023-4-3

[7]
IL-17-driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum.

Mucosal Immunol. 2023-8

[8]
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice.

Nat Biotechnol. 2023-6

[9]
CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium.

EMBO Rep. 2023-2-6

[10]
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.

Cell Oncol (Dordr). 2023-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索